Welcome to our dedicated page for Horizon Space Acquisition I SEC filings (Ticker: HSPOU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to track every charter extension vote, trust-account payment, and potential merger rumor buried in Horizon Space Acquisition I Corp’s (HSPOU) SEC stack? SPAC disclosures introduce extra layers—monthly extension 8-Ks, dense S-4s, and rapid Form 4 sponsor trades—that traditional research screens often miss.
Stock Titan turns that maze into an ordered roadmap. Our AI-powered summaries translate each filing type in real time, whether it’s a 10-Q detailing interest income on the trust or an 8-K material event explained that signals a signed letter of intent. Need the latest Horizon Space Acquisition I Corp insider trading Form 4 transactions? You’ll receive alerts the moment they hit EDGAR—no more manual refreshes. Wondering how the Horizon Space Acquisition I Corp quarterly earnings report 10-Q filing affects redemption values? We surface the key numbers and compare them to prior quarters automatically.
Dig deeper with purpose-built tags:
- Form 4 insider transactions real-time—see every sponsor share movement.
- Annual report 10-K simplified—focus on trust balance, expenses, and deadline.
- Proxy statement executive compensation—understand promote economics and potential dilution.
- Earnings report filing analysis—track interest income that underpins per-share cash.
Regencell Bioscience Holdings Limited (RGC) filed a Form 6-K announcing a board change effective 30 June 2025.
- Appointment: Ms. Margaret Hoor Han Lo joins the board as an independent director and will sit on the audit, compensation, and nominating & corporate governance committees.
- Background: Ms. Lo brings 30+ years of real-estate investment experience and has no family ties to existing officers or directors.
- Resignation: Independent director Mr. Paul J. Niewiadomski resigned for personal reasons on the same date; he previously chaired the nominating & corporate governance committee and served on the audit and compensation committees.
- No disagreements: The company states the resignation was not due to any dispute over operations, policies, or practices. Mr. Niewiadomski will remain in an advisory capacity.
Other than the governance transition, the filing contains no financial or operational updates.